Tolterodine in the treatment of overactive bladder: analysis of the pooled phase II efficacy and safety data

This publication has 14 references indexed in Scilit:

• Serum protein binding of tolterodine and its major metabolites in humans and several animal species
  Biopharmaceutics & Drug Disposition, 1999
• Influence of CYP2D6 polymorphism on the pharmacokinetics and pharmacodynamics of tolterodine*
  Clinical Pharmacology & Therapeutics, 1998
• Antimuscarinic Potency and Bladder Selectivity of PNU‐200577, a Major Metabolite of Tolterodine
  Basic & Clinical Pharmacology & Toxicology, 1997
• A medium term analysis of the subjective efficacy of treatment for women with detrusor instability and low bladder compliance
  BJOG: An International Journal of Obstetrics and Gynaecology, 1997
• Tolterodine – a new bladder-selective antimuscarinic agent
  European Journal of Pharmacology, 1997
• Oxybutynin
  Drugs & Aging, 1995
• Urodynamic and other effects of tolterodine: A novel antimuscarinic drug for the treatment of detrusor overactivity
  Neurourology and Urodynamics, 1995
• Voiding Patterns and Prevalence of Incontinence in Women.: A Questionnaire Survey
  British Journal of Urology, 1990
• Pharmacologic Treatment of Incontinence
  Journal of the American Geriatrics Society, 1990
• Current Concepts in the Treatment of Disorders of Micturition
  Drugs, 1988